Chemotherapy Induced Peripheral Neuropathy Market Gains Momentum...

added blog Teknoloji

2026-06-04 12:58:09

Chemotherapy Induced Peripheral Neuropathy Market Gains Momentum Across the United States

Chemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes. According to market estimates, the chemotherapy induced peripheral neuropathy market is expected to grow from US$ 1.01 billion in 2025 to US$ 1.67 billion by 2034, registering a CAGR of 5.71% during...

0 Comments 0 Shares 42 Views 0 Reviews